There is no established direct conversion ratio between bisoprolol and diltiazem CD
Direct dose conversion between bisoprolol 5 mg and diltiazem CD is not possible because these medications work through fundamentally different mechanisms and lack equivalent dosing data. You must instead initiate diltiazem at standard starting doses and titrate based on clinical response.
Recommended Approach
Start diltiazem CD at 120-180 mg once daily when transitioning from bisoprolol 5 mg, then titrate upward based on heart rate and blood pressure control 1, 2.
Rationale for Starting Dose Selection
- Standard diltiazem CD dosing ranges from 120-360 mg daily for rate control in atrial fibrillation 1, 2
- Bisoprolol 5 mg represents a moderate beta-blocker dose (mid-range of the 2.5-10 mg daily spectrum) 3
- Starting at 120-180 mg diltiazem CD provides conservative initial rate control while allowing room for upward titration
Titration Strategy
After initiating diltiazem CD:
- Assess response at 10-14 days: Check resting heart rate and blood pressure
- Increase to 240 mg daily if inadequate rate control (target resting HR typically 60-100 bpm for AF)
- Further titration to 300-360 mg daily may be needed for optimal control 1, 2
- The dose-response relationship for diltiazem is linear between 240-420 mg 4
Critical Considerations
Overlap Period
Do NOT overlap these medications unless specifically managing a transition period under close monitoring. Both agents slow AV nodal conduction and combining them significantly increases risk of:
- Severe bradycardia
- Heart block
- Hypotension
Patient-Specific Factors
Reduce initial diltiazem dose to 120 mg daily or lower if:
- Hepatic impairment (cirrhosis/hepatitis) - diltiazem undergoes extensive first-pass metabolism 5
- Elderly patients with borderline blood pressure
- Baseline bradycardia (HR <60 bpm)
Contraindications to diltiazem:
- Heart failure with reduced ejection fraction (HFrEF) - explicitly avoid per guidelines 1, 2
- Sick sinus syndrome without pacemaker
- Second or third-degree AV block without pacemaker
Monitoring Requirements
During the transition:
- Check heart rate and blood pressure at baseline, 1-2 weeks, and after each dose adjustment
- ECG monitoring if patient has baseline conduction abnormalities
- Watch for ankle edema (occurs in 2-6% of patients on diltiazem) 4
Why No Direct Conversion Exists
Beta-blockers (bisoprolol) and non-dihydropyridine calcium channel blockers (diltiazem) achieve rate control through different mechanisms:
- Bisoprolol: Beta-1 selective adrenergic blockade
- Diltiazem: Calcium channel blockade at AV node
Their relative potencies vary by individual patient response, baseline sympathetic tone, and clinical context. The 2023 ACC/AHA guidelines list both as rate control options but provide no conversion ratios 1, 2.